Literature DB >> 19479846

The biochemistry of drug metabolism--an introduction: part 5. Metabolism and bioactivity.

Bernard Testa1, Stefanie D Krämer.   

Abstract

This review continues a general presentation of the metabolism of drugs and other xenobiotics begun in five recent issues of Chemistry & Biodiversity. The present Part is dedicated to the pharmacological and toxicological consequences of drug and xenobiotic metabolism. In other words, the key concepts here are activation vs. deactivation, toxification vs. detoxification, and their interplay. These concepts are illustrated with a number of medicinally, toxicologically, and environmentally relevant examples. But, far from being concerned only with individual cases, the review is based on broad classifications, global rationalizations, and synthetic hypotheses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19479846     DOI: 10.1002/cbdv.200900022

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  8 in total

Review 1.  Molecular mechanisms underlying chemical liver injury.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Expert Rev Mol Med       Date:  2012-02-03       Impact factor: 5.600

2.  Metabolite profiling of praziquantel and its analogs during the analysis of in vitro metabolic stability using information-dependent acquisition on a hybrid triple quadrupole linear ion trap mass spectrometer.

Authors:  Jiangeng Huang; Sai Praneeth R Bathena; Yazen Alnouti
Journal:  Drug Metab Pharmacokinet       Date:  2010-09-22       Impact factor: 3.614

3.  Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock: a parallelized tool based on AutoDock 4.0.

Authors:  Giulio Vistoli; Alessandro Pedretti; Angelica Mazzolari; Bernard Testa
Journal:  J Comput Aided Mol Des       Date:  2010-07-11       Impact factor: 3.686

4.  Molecular Docking-Based Design and Development of a Highly Selective Probe Substrate for UDP-glucuronosyltransferase 1A10.

Authors:  Risto O Juvonen; Sanna Rauhamäki; Sami Kortet; Sanna Niinivehmas; Johanna Troberg; Aleksanteri Petsalo; Juhani Huuskonen; Hannu Raunio; Moshe Finel; Olli T Pentikäinen
Journal:  Mol Pharm       Date:  2018-02-15       Impact factor: 4.939

5.  A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment.

Authors:  Titilayo Omolara Johnson; Abayomi Emmanuel Adegboyega; Oluwafemi Adeleke Ojo; Amina Jega Yusuf; Opeyemi Iwaloye; Chinenye Jane Ugwah-Oguejiofor; Rita Onyekachukwu Asomadu; Ifeoma Felicia Chukwuma; Stephen Adakole Ejembi; Emmanuel Ike Ugwuja; Saqer S Alotaibi; Sarah M Albogami; Gaber El-Saber Batiha; Bodour S Rajab; Carlos Adam Conte-Junior
Journal:  Front Med (Lausanne)       Date:  2022-06-15

6.  Use of 3-[(18)F]fluoropropanesulfonyl chloride as a prosthetic agent for the radiolabelling of amines: Investigation of precursor molecules, labelling conditions and enzymatic stability of the corresponding sulfonamides.

Authors:  Reik Löser; Steffen Fischer; Achim Hiller; Martin Köckerling; Uta Funke; Aurélie Maisonial; Peter Brust; Jörg Steinbach
Journal:  Beilstein J Org Chem       Date:  2013-05-27       Impact factor: 2.883

7.  Synthesis, Characterization, Antimicrobial Activity, and Genotoxicity Assessment of Two Heterocyclic Compounds Containing 1,2,3-Selena- or 1,2,3-Thiadiazole Rings.

Authors:  Mousa L Al-Smadi; Reem Mansour; Amjad Mahasneh; Omar F Khabour; Majed M Masadeh; Karem H Alzoubi
Journal:  Molecules       Date:  2019-11-12       Impact factor: 4.411

8.  Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2.

Authors:  Titilayo O Johnson; Abayomi Emmanuel Adegboyega; Opeyemi Iwaloye; Omokehinde Abiodun Eseola; Winfried Plass; Boluwatife Afolabi; Damilare Rotimi; Eman I Ahmed; Ashraf Albrakati; Gaber E Batiha; Oluyomi Stephen Adeyemi
Journal:  J Pharmacol Sci       Date:  2021-05-23       Impact factor: 3.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.